Biotechnology Research: Priorities and Public Policy Implications

When: Thursday, December 11, 2003

Where: Ottawa

Speakers at this session included Dr. Ronald Worton, CEO and Scientific Director of the new Ottawa Health Research Institute and Vice President of Research at the Ottawa Hospital, and Dr. Carolyn Bennett, MP (St. Paul's).